Bruce W. Robinson

35 Stirling Highway
Crawley, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Journal: Vaccines

Published: December 01, 2025

Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis.

Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis.

Journal: Cancer immunology, immunotherapy : CII

Published: May 10, 2025

Circulating stem-like exhausted CD8 T cells point to better outcomes in lung cancer: a brief report.

Circulating stem-like exhausted CD8 T cells point to better outcomes in lung cancer: a brief report.

Journal: Translational lung cancer research

Published: May 04, 2025

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Journal: Oxford open immunology

Published: December 10, 2024

Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.

Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma.

Journal: Translational lung cancer research

Published: April 01, 2024

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.

The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.

Journal: Frontiers in toxicology

Published: January 19, 2024

Computational immunogenomic approaches to predict response to cancer immunotherapies.

Computational immunogenomic approaches to predict response to cancer immunotherapies.

Journal: Nature reviews. Clinical oncology

Published: October 03, 2023

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.

Journal: Vaccines

Published: April 14, 2022

What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.

What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.

Journal: Oncoimmunology

Published: February 21, 2022

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies.

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies.

Journal: Frontiers in pharmacology

Published: January 20, 2022

Why we still need drugs for COVID-19 and can't just rely on vaccines.

Why we still need drugs for COVID-19 and can't just rely on vaccines.

Journal: Respirology (Carlton, Vic.)

Published: December 07, 2021

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.

Journal: ESMO open

Published: October 21, 2021

Showing 1-12 of 85

Last Updated: 09/26/2026